News About: Pharm. Industry
Pfizer Korea to extend Viagra patent
The Korean unit of Pfizer Inc. is seeking to extend Viagra patent, which covers the indication for which the drug is used. That patent expires in October 2019. The US composition-of-matter patent is set to expire in M...
Big gap of OTC drug price prevailing per region
A survey of popular over-the-counter drugs nationwide showed that their price gap is bigger.
For example, the average price of Antiphlamine ointment by Yuhan is 1,025 won in Kwangju of Cholla Province while it is 6...
Bacchus-F sales high at convenient stores
Dong-A’s popular energy drink, Bacchus-F, has been popular during Chuseok season after it supplied the product directly to non-pharmacy retailers across the country starting September 8.
A convenient store owner sa...
Dong-A teams up with GSK
Dong-A Pharmaceutical, Korea’s largest drug manufacturer, said Thursday that it has established a marketing and distribution partnership with GlaxoSmithKline (GSK), the world’s third largest pharmaceutical firm by rev...
European healthcare business delegation readies for promoting partnership
A European Union delegation of 37 companies focusing on healthcare and medical technologies are set to an exhibition at the COEX Convention Center Grand Ballroom on July 27-28.
The Gateway Program is comprised of 5...
Pfizer's Viagra to faces stiff competition
Pfizer, which so far has been leading the domestic erectile dysfunction drugs market with its flagship medicine Viagra, will face a fiercer competition as the patent on Viagra expires in May 17 of 2012.
Currently, ...
Could Zepid be viable in domestic anti-impotence drug market?
The Korea Food and Drug Administration (KFDA) recently approved the domestic sale of Zepid, a new type of anti-impotency drug.
Created by JW Pharmaceutical, Zepid is expected to be launched in the last quarter of t...
FKCU demands job stabilization
The Federation of Korean Chemical Workers’ Unions (FKCU) protested against the government, Thursday, demanding it provide full guarantees of job stabilization in the domestic pharmaceutical industry.
The move comes...
Korea’s new drug pricing reform faces backlash
The government’s plan to cut drug prices by an average of 17 percent starting next year has triggered vehement protests from the domestic pharmaceutical community.
An alliance of 10 pharmaceutical-related organiza...
JW Pharmaceutical Group names foreign CSO
JW Pharmaceutical Group has hired a foreign R&D expert to lead its global business operations.
The company said Wednesday it appointed Dr. Glenn Noronha, a senior scientist of Pharmaceutical Development at Novartis...
